Are you sure you want to change languages?
The page you are visiting uses a different locale than your saved profile. Do you want to change your locale?
Antigen tests are faster, cheaper and more scalable than the familiar molecular test for COVID-19. A new multibillion market could open up if the health care industry manages to establish a threshold for test accuracy. Broader acceptance of antigen tests should also bring significant revenue growth for the handful of public companies that have such products in the market today.